Ud fra data om enzyminduktion og - inhibition er der ikke teoretisk grundlag for at forvente metaboliske interaktioner mellem fluticasonfuroat og cytokrom- P450- medieret metabolisme af andre stoffer ved klinisk relevante intranasale doser.
The enzyme induction and inhibition data suggest that there is no theoretical basis for anticipating metabolic interactions between fluticasone furoate and the cytochrome P450 mediated metabolism of other compounds at clinically relevant intranasal doses.